The lack of in vitro tissue and organ
models capable of mimicking
human physiology severely hinders the development and clinical translation
of therapies and drugs with higher in vivo efficacy. Bioprinting allow
us to fill this gap and generate 3D tissue analogues with complex
functional and structural organization through the precise spatial
positioning of multiple materials and cells. In this review, we report
the latest developments in terms of bioprinting technologies for the
manufacturing of cellular constructs with particular emphasis on material
extrusion, jetting, and vat photopolymerization. We then describe
the different base polymers employed in the formulation of bioinks
for bioprinting and examine the strategies used to tailor their properties
according to both processability and tissue maturation requirements.
By relating function to organization in human development, we examine
the potential of pluripotent stem cells in the context of bioprinting
toward a new generation of tissue models for personalized medicine.
We also highlight the most relevant attempts to engineer artificial
models for the study of human organogenesis, disease, and drug screening.
Finally, we discuss the most pressing challenges, opportunities, and
future prospects in the field of bioprinting for tissue engineering
(TE) and regenerative medicine (RM).